Cerebral Vasospasm
38
1
2
16
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
21.1%
8 terminated out of 38 trials
66.7%
-19.8% vs benchmark
8%
3 trials in Phase 3/4
44%
7 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (38)
Cervical Spinal Cord Stimulation in Patients With Cerebral Vasospasm After Subarachnoid Haemorrhage: VasoStim Study
Cervical Sympathetic Block in Patients With Cerebral Vasospasm
Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers.
The Intra-arterial Vasospasm Trial
Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm
Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage
Identification of Novel Molecular Markers for Vasospasm
Stellate Ganglion Block and Cerebral Vasospasm
"The Effect of Stellate Ganglion Block in Severe Brain Injury"
Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm
Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study)
Magnesium Treating Subarachnoid Hemorrhage Vasospasm
Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm
Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm
Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage
Sildenafil for DCI
Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage
Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage